Actively Recruiting
Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization
Led by AHEPA University Hospital · Updated on 2025-02-11
80
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the RIVA-RAO study is to determine whether the use of Rivaroxaban is an effective treatment of radial artery occlusion (RAO) after cardiac catheterization (both angiography and PCI). This is a prospective, single-center, randomized controlled, open-label study that will randomize patients with RAO into two groups, one receiving Rivaroxaban and the other receiving no anticoagulation. RAO will be detected by radial artery ultrasound up to 24 hours after the procedure. Study objectives: Primary objective: To evaluate the effect of treatment with Rivaroxaban, in patients (both symptomatic and asymptomatic) with RAO after a coronary catheterization procedure (both angiography and percutaneous coronary intervention-PCI), in improving patency rates of the radial artery at 4 weeks after the procedure, compared with no-anticoagulation treatment. Secondary objectives: To compare local access site and systemic complications (bleeding events, pseudoaneurysm, arteriovenous fistula) at 4 weeks after the procedure between the two groups.
CONDITIONS
Official Title
Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of any gender undergoing coronary catheterization (angiography or PCI) through the radial artery with at least one radial artery sheath inserted
- Radial artery occlusion confirmed by ultrasound (2D, Doppler, colour)
You will not qualify if you...
- Under 18 years of age
- Unable to provide informed written consent
- Any contraindication to receiving Rivaroxaban
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
AHEPA University Hospital
Thessaloniki, Greece, 54636
Actively Recruiting
Research Team
M
Matthaios Didagelos, MD, MSc, PhD
CONTACT
A
Areti Pagiantza, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here